Igor DaCruz is a vice president for SVB’s Southwest Life Science practice in San Diego, where he manages a portfolio of biotech and diagnostic companies. Whether his clients need to simplify their financial operations or extend their existing runway, Igor forges innovative solutions that allow them to stay focused on achieving their goals. He’s passionate about his front-row seat in the sector, where he can watch, in real time, as the most cutting-edge companies develop breakthrough therapies and revolutionize the way we treat — and sometimes cure — disease.
Igor has specialized in meeting the unique financial demands of life science firms throughout his career. He joined SVB Boston in 2011 as an associate in the specialty finance division. In this role, he provided financial analysis and credit underwriting for companies in the life science sector. He relocated to SVB San Diego in 2013, where as a senior associate, he supported a broad range of life science companies, including biotech, diagnostic, medical device and healthcare IT enterprises. In 2017, Igor completed a three-month rotation in SVB’s joint venture in China, where he helped develop the bank’s life science expertise in that growing market and also served as a bridge between the teams in the United States and China. . Igor holds a bachelor’s degree in management with a concentration in finance from the University of Massachusetts, Boston.
While in Hong Kong, Igor was part of a four-person team that helped raise more than HK$42,000 for Oxfam, a global nonprofit that works in more than 90 countries to end the injustice of poverty. As part of the fundraising efforts, Igor and his team completed a 100-kilometer nonstop trail walk that lasted 39 hours and 15 minutes.
Born and raised in Brazil and fluent in English, Portuguese and Spanish, Igor attended high school in Boston, where he lived until moving to San Diego. In his free time, Igor’s interests include judo, outdoor climbing, travel and craft beer. He’s also an avid soccer enthusiast. In fact, after high school, he tried out for the New England Revolution, a major-league soccer team — but he decided he’d rather become a banker instead (he says with a wink).
Life Science & Healthcare